AEHR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aehr Test Systems (AEHR).


$332.81M Market Cap.

As of 07/30/2024 5:00 PM ET (MRY) • Disclaimer

AEHR Market Cap. (MRY)


AEHR Shares Outstanding (MRY)


AEHR Assets (MRY)


Total Assets

$127.91M

Total Liabilities

$16.32M

Total Investments

$0

AEHR Income (MRY)


Revenue

$66.22M

Net Income

$33.16M

Operating Expense

$22.46M

AEHR Cash Flow (MRY)


CF Operations

$1.76M

CF Investing

$17.25M

CF Financing

$139.00K

AEHR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AEHR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$127,912,000 (30.33%)

$98,143,000 (57.46%)

$62,328,000 (187.69%)

$21,665,000 (5.30%)

Assets Current

$97,848,000 (9.90%)

$89,030,000 (48.37%)

$60,007,000 (212.80%)

$19,184,000 (8.69%)

Assets Non-Current

$30,064,000 (229.90%)

$9,113,000 (292.63%)

$2,321,000 (-6.45%)

$2,481,000 (-15.12%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$111,593,000 (47.61%)

$75,600,000 (48.27%)

$50,989,000 (345.36%)

$11,449,000 (-18.67%)

Property Plant & Equipment Net

$8,987,000 (1.18%)

$8,882,000 (318.96%)

$2,120,000 (-7.14%)

$2,283,000 (-17.58%)

Cash & Equivalents

$49,159,000 (63.57%)

$30,054,000 (-4.54%)

$31,484,000 (587.12%)

$4,582,000 (-15.66%)

Accumulated Other Comprehensive Income

-$158,000 (-1.94%)

-$155,000 (-47.62%)

-$105,000 (-275.00%)

-$28,000 (-101.25%)

Deferred Revenue

$1,386,000 (-51.42%)

$2,853,000 (14.86%)

$2,484,000 (762.50%)

$288,000 (50.00%)

Total Investments

$0 (0%)

$17,853,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$17,853,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$37,470,000 (56.73%)

$23,908,000 (58.85%)

$15,051,000 (70.09%)

$8,849,000 (10.76%)

Trade & Non-Trade Receivables

$9,796,000 (-40.97%)

$16,594,000 (29.05%)

$12,859,000 (147.19%)

$5,202,000 (39.95%)

Trade & Non-Trade Payables

$5,332,000 (-42.08%)

$9,206,000 (119.45%)

$4,195,000 (45.01%)

$2,893,000 (206.14%)

Accumulated Retained Earnings (Deficit)

-$19,150,000 (63.39%)

-$52,306,000 (21.77%)

-$66,863,000 (12.38%)

-$76,313,000 (-2.73%)

Tax Assets

$20,773,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$6,197,000 (-1.63%)

$6,300,000 (526.24%)

$1,006,000 (-79.14%)

$4,823,000 (22.35%)

Debt Current

$465,000 (239.42%)

$137,000 (-82.75%)

$794,000 (-79.19%)

$3,816,000 (191.08%)

Debt Non-Current

$5,732,000 (-6.99%)

$6,163,000 (2807.08%)

$212,000 (-78.95%)

$1,007,000 (-61.73%)

Total Liabilities

$16,319,000 (-27.61%)

$22,543,000 (98.81%)

$11,339,000 (10.99%)

$10,216,000 (56.74%)

Liabilities Current

$10,508,000 (-35.57%)

$16,308,000 (48.07%)

$11,014,000 (21.55%)

$9,061,000 (134.44%)

Liabilities Non-Current

$5,811,000 (-6.80%)

$6,235,000 (1818.46%)

$325,000 (-71.86%)

$1,155,000 (-56.46%)

AEHR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$66,218,000 (1.94%)

$64,961,000 (27.80%)

$50,829,000 (206.20%)

$16,600,000 (-25.53%)

Cost of Revenue

$33,675,000 (4.53%)

$32,215,000 (18.59%)

$27,164,000 (157.04%)

$10,568,000 (-24.08%)

Selling General & Administrative Expense

$13,746,000 (12.33%)

$12,237,000 (21.80%)

$10,047,000 (53.11%)

$6,562,000 (-12.86%)

Research & Development Expense

$8,719,000 (22.22%)

$7,134,000 (22.62%)

$5,818,000 (59.31%)

$3,652,000 (7.86%)

Operating Expenses

$22,465,000 (15.97%)

$19,371,000 (22.10%)

$15,865,000 (55.33%)

$10,214,000 (-8.28%)

Interest Expense

$0 (0%)

-$1,245,000 (-9476.92%)

-$13,000 (-128.26%)

$46,000 (560.00%)

Income Tax Expense

-$20,698,000 (-34596.67%)

$60,000 (-34.07%)

$91,000 (151.41%)

-$177,000 (-591.67%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$33,156,000 (127.77%)

$14,557,000 (54.04%)

$9,450,000 (566.21%)

-$2,027,000 (27.66%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$33,156,000 (127.77%)

$14,557,000 (54.04%)

$9,450,000 (566.21%)

-$2,027,000 (27.66%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$33,156,000 (127.77%)

$14,557,000 (54.04%)

$9,450,000 (566.21%)

-$2,027,000 (27.66%)

Weighted Average Shares

$28,818,000 (3.72%)

$27,785,000 (6.81%)

$26,014,000 (10.90%)

$23,457,000 (2.51%)

Weighted Average Shares Diluted

$29,617,000 (1.38%)

$29,215,000 (5.19%)

$27,774,000 (18.40%)

$23,457,000 (2.51%)

Earning Before Interest & Taxes (EBIT)

$12,458,000 (-6.84%)

$13,372,000 (40.34%)

$9,528,000 (541.52%)

-$2,158,000 (22.26%)

Gross Profit

$32,543,000 (-0.62%)

$32,746,000 (38.37%)

$23,665,000 (292.32%)

$6,032,000 (-27.94%)

Operating Income

$10,078,000 (-24.65%)

$13,375,000 (71.47%)

$7,800,000 (286.51%)

-$4,182,000 (-51.25%)

AEHR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$17,251,000 (192.47%)

-$18,656,000 (-4384.62%)

-$416,000 (-83.26%)

-$227,000 (-39.26%)

Net Cash Flow from Financing

$139,000 (-98.10%)

$7,322,000 (-71.58%)

$25,761,000 (1214.34%)

$1,960,000 (-9.76%)

Net Cash Flow from Operations

$1,756,000 (-82.46%)

$10,011,000 (563.86%)

$1,508,000 (155.83%)

-$2,701,000 (-33.45%)

Net Cash Flow / Change in Cash & Cash Equivalents

$19,105,000 (1504.78%)

-$1,360,000 (-105.06%)

$26,902,000 (3261.22%)

-$851,000 (-17120.00%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$18,000,000 (204.08%)

-$17,294,000 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$749,000 (45.01%)

-$1,362,000 (-227.40%)

-$416,000 (-83.26%)

-$227,000 (-39.26%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$1,400,000 (-200.00%)

$1,400,000 (-16.62%)

Issuance (Purchase) of Equity Shares

$139,000 (-98.10%)

$7,322,000 (-73.04%)

$27,161,000 (4750.18%)

$560,000 (13.59%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$41,000 (-10.81%)

-$37,000 (-175.51%)

$49,000 (-58.12%)

$117,000 (485.00%)

Share Based Compensation

$2,518,000 (-8.37%)

$2,748,000 (-8.58%)

$3,006,000 (173.02%)

$1,101,000 (20.99%)

Depreciation Amortization & Accretion

$1,363,000 (153.35%)

$538,000 (75.24%)

$307,000 (-0.97%)

$310,000 (-19.27%)

AEHR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

49.10% (-2.58%)

50.40% (8.15%)

46.60% (28.37%)

36.30% (-3.46%)

Profit Margin

50.10% (123.66%)

22.40% (20.43%)

18.60% (252.46%)

-12.20% (3.17%)

EBITDA Margin

20.90% (-2.34%)

21.40% (10.88%)

19.30% (273.87%)

-11.10% (-3.74%)

Return on Average Equity (ROAE)

36.30% (57.14%)

23.10% (-8.33%)

25.20% (240.00%)

-18.00% (0.55%)

Return on Average Assets (ROAA)

30.40% (62.57%)

18.70% (0.00%)

18.70% (276.42%)

-10.60% (16.54%)

Return on Sales (ROS)

18.80% (-8.74%)

20.60% (10.16%)

18.70% (243.85%)

-13.00% (-4.00%)

Return on Invested Capital (ROIC)

23.00% (-23.84%)

30.20% (-58.17%)

72.20% (517.34%)

-17.30% (4.95%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

10.01 (-84.24%)

63.5 (172.79%)

23.28 (193.11%)

-25 (-81.82%)

Price to Sales Ratio (P/S)

5.01 (-64.53%)

14.12 (229.28%)

4.29 (34.92%)

3.18 (87.66%)

Price to Book Ratio (P/B)

2.98 (-75.91%)

12.38 (179.71%)

4.42 (-4.59%)

4.64 (71.91%)

Debt to Equity Ratio (D/E)

0.15 (-51.01%)

0.3 (34.23%)

0.22 (-75.11%)

0.89 (92.66%)

Earnings Per Share (EPS)

1.15 (121.15%)

0.52 (44.44%)

0.36 (500.00%)

-0.09 (25.00%)

Sales Per Share (SPS)

2.3 (-1.71%)

2.34 (19.65%)

1.95 (175.99%)

0.71 (-27.31%)

Free Cash Flow Per Share (FCFPS)

0.04 (-88.75%)

0.31 (640.48%)

0.04 (133.60%)

-0.13 (-30.21%)

Book Value Per Share (BVPS)

3.87 (42.30%)

2.72 (38.83%)

1.96 (301.64%)

0.49 (-20.65%)

Tangible Assets Book Value Per Share (TABVPS)

4.44 (25.68%)

3.53 (47.41%)

2.4 (159.31%)

0.92 (2.78%)

Enterprise Value Over EBIT (EV/EBIT)

23 (-66.67%)

69 (245.00%)

20 (180.00%)

-25 (-92.31%)

Enterprise Value Over EBITDA (EV/EBITDA)

21.09 (-68.28%)

66.49 (235.74%)

19.8 (168.61%)

-28.86 (-95.42%)

Asset Turnover

0.61 (-27.22%)

0.83 (-17.18%)

1.01 (15.75%)

0.87 (-13.60%)

Current Ratio

9.31 (70.58%)

5.46 (0.20%)

5.45 (157.35%)

2.12 (-53.65%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$1,007,000 (-88.36%)

$8,649,000 (692.03%)

$1,092,000 (137.30%)

-$2,928,000 (-33.88%)

Enterprise Value (EV)

$291,533,531 (-68.48%)

$924,931,661 (374.84%)

$194,786,290 (265.16%)

$53,342,892 (50.97%)

Earnings Before Tax (EBT)

$12,458,000 (-14.77%)

$14,617,000 (53.20%)

$9,541,000 (532.89%)

-$2,204,000 (20.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$13,821,000 (-0.64%)

$13,910,000 (41.43%)

$9,835,000 (632.20%)

-$1,848,000 (22.74%)

Invested Capital

$74,442,000 (28.17%)

$58,081,000 (178.75%)

$20,836,000 (62.21%)

$12,845,000 (-15.59%)

Working Capital

$87,340,000 (20.10%)

$72,722,000 (48.43%)

$48,993,000 (383.98%)

$10,123,000 (-26.57%)

Tangible Asset Value

$127,912,000 (30.33%)

$98,143,000 (57.46%)

$62,328,000 (187.69%)

$21,665,000 (5.30%)

Market Capitalization

$332,808,531 (-64.43%)

$935,727,661 (314.75%)

$225,613,290 (324.92%)

$53,094,892 (39.82%)

Average Equity

$91,347,250 (44.75%)

$63,104,750 (68.20%)

$37,517,750 (233.14%)

$11,261,750 (-27.28%)

Average Assets

$109,038,000 (39.94%)

$77,915,000 (54.39%)

$50,467,250 (164.37%)

$19,089,500 (-13.80%)

Invested Capital Average

$54,057,750 (22.04%)

$44,294,500 (235.51%)

$13,202,250 (5.65%)

$12,496,000 (-18.12%)

Shares

28,914,729 (2.03%)

28,338,209 (5.26%)

26,922,827 (14.09%)

23,597,730 (2.53%)